The need for therapies to treat infectious disease has never been more urgent. Synteract, an infectious disease CRO and vaccine CRO with extensive experience, continues to work across a spectrum of pharma, biotech, and device/diagnostic companies to meet the needs of public health. We work with the best sites and implement rapid start-up pathways, while navigating the changing regulatory landscape at local, regional, and global levels, so that our customers can achieve their enrollment targets and meet study milestones.

Infectious Disease and Vaccine Experience:

Synteract’s study teams understand the complexities of infectious disease and vaccines trials, from accelerated patient enrollment to maintaining specimen integrity to ever-changing timelines. Synteract offers customers a variety of infectious disease and vaccine CRO services:

• Pediatric and adult enrollment strategies
• Feasibility assessment and site selection
• Regulatory Affairs
• Medical Affairs
• Study and protocol design consulting
• Clinical Operations
• Biostatistics
• Data management
• Project management
• FSP
• Medical Writing
• Safety Management

130+ projects across a variety of indications:

“Each clinical trial for infectious diseases and vaccines is unique and nuanced. With our deep understanding of these trials, we can ensure that patients are enrolled and critical timelines are achieved so these products get to market quickly.”

Scott Treiber, VP, Strategic Development at Synteract

At Synteract we rely on proven strategies to help minimize risk and deliver quality data as we bring your clinical trial to life.